FDA Status
Not FDA-Approved
Trials are for parent compound thymosin beta-4, not TB-500
Claimed Benefits
- Tissue repair
- Wound healing
- Inflammation reduction
- Musculoskeletal recovery
Clinical Evidence
5
Human Trials
Phase III
Highest Phase
All clinical trials are for full-length thymosin beta-4 (RGN-259); no human trials exist specifically for TB-500.
Read Full Deep Dive
Mechanism, dosing, vendor pricing, and full research citations